MoneyWorks4Me

SMS Lifescience receives EIR from USFDA for Kazipally Unit

18 Jun 2018 Evaluate

SMS Lifescience India has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection conducted in April 2018, at its manufacturing facility - Unit-I, located at Kazipally, Medak district in Hyderabad.

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..